Stock Name: PHARMACompany Name: PHARMANIAGA BHDResearch House: HLG | Price Call: BUY | Target Price: 9.17 |
KUALA LUMPUR: Hong Leong Investment Bank (HLIB) has maintained a "buy" rating on the largest integrated local healthcare company in Malaysia, Pharmaniaga Bhd, even after lowering the target price from RM9.41 to RM9.17.
In a research note today, HLIB reaffirmed Pharmaniaga's bullish stance and its business strategies going forward, to capture more opportunities presented by the domestic as well as the regional healthcare industries which areresiliently growing.
"Besides supplying hemodialysis medical equipment under the memorandum of understanding (MOU) with Pusat Pakar Dialysis Traktif Sdn Bhd last week,Pharmaniaga has also positioned itself as the vendor of related drugs and consumables in order to enjoy recurring income for the deal," it said.
Following the MOU, Pharmaniaga may be reviving its medical products and services business division, which was laid low in financial year 2011, HLIB said.
Pharmaniaga' share was at RM8.45 at midday today.-- BERNAMA